Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 28Active not recruiting 13Recruiting 10Unknown 6Terminated 3Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Specimen Handling 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Trastuzumab 2Taxes 2Tamoxifen 2Interleukin-2 2Fluorouracil 2Cyclophosphamide 2Biopsy 2Anastrozole 2trastuzumab biosimilar HLX02 1taletrectinib 1palbociclib 1fluzoparib 1exemestane 1eribulin 1binimetinib 1aldesleukin 1Tomography, Optical Coherence 1Testosterone Propionate 1Testosterone 1Tablets 1Receptors, Chimeric Antigen 1Radiotherapy 1Radiosurgery 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Methods × Breast × Clear all
NCT02993068 2026-02-19

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

M.D. Anderson Cancer Center

Phase NA Suspended
5,200 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡